Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :213
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed5102    
    Printed186    
    Emailed4    
    PDF Downloaded676    
    Comments [Add]    
    Cited by others 26    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2009  |  Volume : 46  |  Issue : 3  |  Page : 194-202

Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer


1 Biochemistry Research Division, The Gujarat Cancer and Research Institute, Ahmedabad - 380 016, India
2 Medical Oncology Department, The Gujarat Cancer and Research Institute, Ahmedabad - 380 016, India
3 Surgical Oncology Department, The Gujarat Cancer and Research Institute, Ahmedabad - 380 016, India

Correspondence Address:
P S Patel
Biochemistry Research Division, The Gujarat Cancer and Research Institute, Ahmedabad - 380 016
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0019-509X.52953

Rights and Permissions

Background: Invasion and metastasis are the most strenuous problems in the management of breast cancer. These events require diverse proteolytic enzymes, among which MMP-2 and MMP-9 play a significant role in degradation of type IV collagen, the major component of the basement membrane. Therefore, the major objective of the study is to evaluate the clinical usefulness of MMP-2 and MMP-9 with respect to malignant tumor growth, invasion, and metastasis in breast cancer. Materials and Methods: Gelatin zymography was performed on 157 tissue extracts of malignant and adjacent normal breast tissues as well as negative and positive lymph nodes from 49 breast cancer patients. Statistical analysis was carried out using SPSS statistical software (version 10). Results: ProMMP-2 levels were significantly higher in adjacent normal tissues. Active MMP-2 and MMP-9 levels were higher in malignant breast tissues. Activation ratios of MMP-2 and MMP-9 were significantly higher in malignant breast tissues and in patients with lymph node metastasis. ProMMP-2, active MMP-2, and active MMP-9 could significantly discriminate between malignant and adjacent normal breast tissues. The MMP-2 activation ratio showed significant discriminatory efficacy between patients with and without lymph node metastasis and significant association with increased risk of lymph node metastasis in node-negative patients. Conclusion: The results indicate significant clinical utility of these proteolytic enzymes in malignant tumor growth, invasion, and metastasis in breast cancer.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow